Metagenomi Therapeutics, Inc.
MGX
$1.46
-$0.02-1.35%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 160.80M | 184.11M | 204.99M | 225.97M | 248.31M |
| Total Receivables | 1.51M | 2.26M | 2.27M | 2.61M | 2.86M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 3.23M | 3.45M | 4.42M | 4.61M | 6.80M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 165.54M | 189.82M | 211.68M | 233.20M | 257.96M |
|
|
|||||
| Total Current Assets | 165.54M | 189.82M | 211.68M | 233.20M | 257.96M |
| Net Property, Plant & Equipment | 47.38M | 49.91M | 52.40M | 55.20M | 57.66M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 6.03M | 6.06M | 6.05M | 6.03M | 5.54M |
| Total Assets | 221.10M | 247.94M | 272.28M | 297.87M | 324.60M |
|
|
|||||
| Total Accounts Payable | 1.49M | 1.22M | 2.89M | 2.67M | 533.00K |
| Total Accrued Expenses | 6.72M | 9.90M | 5.90M | 6.10M | 8.35M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 6.03M | 5.57M | 5.51M | 5.60M | 5.59M |
| Total Finance Division Other Current Liabilities | 8.70M | 12.90M | 18.97M | 25.52M | 22.84M |
| Total Other Current Liabilities | 8.70M | 12.90M | 18.97M | 25.52M | 22.84M |
| Total Current Liabilities | 22.93M | 29.58M | 33.27M | 39.89M | 37.31M |
|
|
|||||
| Total Current Liabilities | 22.93M | 29.58M | 33.27M | 39.89M | 37.31M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 34.63M | 36.09M | 37.48M | 38.83M | 40.19M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 4.94M | 3.82M | 5.71M | 6.48M | 12.25M |
| Total Liabilities | 62.51M | 69.49M | 76.45M | 85.21M | 89.74M |
|
|
|||||
| Common Stock & APIC | 469.21M | 466.42M | 463.41M | 460.08M | 457.15M |
| Retained Earnings | -310.87M | -288.34M | -267.95M | -248.04M | -223.00M |
| Treasury Stock & Other | 260.00K | 371.00K | 372.00K | 621.00K | 709.00K |
| Total Common Equity | 158.60M | 178.45M | 195.83M | 212.66M | 234.86M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 158.60M | 178.45M | 195.83M | 212.66M | 234.86M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 158.60M | 178.45M | 195.83M | 212.66M | 234.86M |
|
|
|||||